Onc bladder mrna 219 gen alg
Genetic testing to determine ovarian cancer risk.
![](https://cdn.prod.website-files.com/66696aaf725cd387430df1eb/66696aaf725cd387430df64c_upvio-learn-more.webp)
![](https://cdn.prod.website-files.com/66696aaf725cd387430df216/66696aaf725cd387430dfd8f_rec9xRLBm9Y2CeR62.jpeg)
CPT code 0016M encompasses a comprehensive laboratory procedure for the assessment of genetic mutations associated with cancer risk. This code is vital for identifying cancer-related mutations, offering insights for personalized cancer risk assessment and management.